Particulate Matters: Categorizations, Considerations, and Compendia

Particulate matter, as defined by the USP, refers to the presence of mobile undissolved particles in solutions, excluding gas bubbles. It is a critical aspect to consider for those involved in packaging injectable drug products, requiring a thorough understanding, mitigation, and adherence to regulatory standards. During this exclusive webinar, experts will delve into the fundamental aspects of categorizing, considering, and complying with particulate matter.

Key Learning Objectives:

• Understand the various categories of particulate and how they are classified and monitored by regulatory authorities
• Understand the risks and challenges injectable drug developers and their packaging suppliers must consider regarding particulate
• Learn best practices for how to mitigate particulate in pharmaceutical packaging manufacturing and supply

Who Should Attend:

• Quality/regulatory personnel in parenteral drug delivery
• Formulation scientists and packaging engineers
• Device development engineers and managers
• Technical functions surrounding drug delivery systems
• Extractable and leachable experts
• Procurement professionals

Gabrielle Gabrielle attended college at Widener University. In that time, she earned both a Bachelor’s and Master’s degree in Biomedical Engineering, graduating with honors. In May of 2019, she entered the pharmaceutical packaging industry in a technical, customer-facing role, recommending and evaluating packaging components for major drug companies.
 Since then, Gabrielle has worked in multiple customer-facing technical roles at two of the leading pharmaceutical packaging companies in the world. Through COVID-19 and the aftermath, she has supported major biologics, generics, and pharma companies to provide high-quality products to their patients. Gabrielle currently serves as a Technical and Scientific Expert on Datwyler's Technical and Scientific Support team.

Speaker's Email: gabrielle.gehron@datwyler.com
Speaker's LinkedIn: Gabrielle Gehron